Fiche technique
Frequently asked questions (FAQs) on Bundibugyo Virus Disease vaccines and therapeutics
This FAQ provides key information on vaccines and therapeutics for Bundibugyo virus disease (BVD), including current evidence, ongoing research, WHO recommendations, and key messages for national authorities and communities.
This document will be updated as new information becomes available.
Langues
Année de publication
2026
Type
Fiche technique
Catégories
- Gestion de programme
Maladies
- Ebola
Pays
- République démocratique du Congo
Organisations
- Organisation Mondiale de la Santé (OMS)
ebola-BDBV
Vous pouvez trouver plus d’informations sur "ebola-BDBV" dans les rubriques suivantes :
| Titre | Auteur | Année | Type | Langue |
|---|---|---|---|---|
| Frequently asked questions (FAQs) on Bundibugyo Virus Disease vaccines and therapeutics | World Health Organization (WHO), WHO Regional Office for Africa (AFRO) | 2026 | Datasheet | Anglais, Français |
| WHO emergency guidance on the use of licensed Ebola virus vaccine during Bundibugyo virus disease outbreaks, 28 May 2026 | World Health Organization (WHO) | 2026 | Guidance | Anglais |
| WHO Technical Advisory Group on Candidate Vaccine Prioritization Meeting report, 19 and 25 May 2026 | World Health Organization (WHO) | 2026 | Report | Anglais |
| GNN webinar: Updates on existing and pipeline Ebola vaccines | Helen Rees, Reena Doshi, Alejandro Costa, Melanie Marti, Pierre Gsell | 2026 | Webinar | Anglais |
